Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBSC and MSCs for Poor Graft Function after Allo-HSCT
NCT02083718Phase 2Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in poor graft function (PGF), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
poor graft function (PGF)
Beyond the preview
Go deeper on NCT02083718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02083718.